Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Kailera Therapeutics, Inc. (KLRA) had Pre-Tax Income of $-148.96M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-148.96M |
|
-- |
|
-- |
|
$158.34M |
|
$-158.34M |
|
$9.38M |
|
|
Pre-Tax Income |
$-148.96M |
$-148.96M |
|
$-148.96M |
|
$-148.96M |
|
$-148.96M |
|
$-148.96M |
|
$-158.34M |
|
$-158.03M |
|
0.00M |
|
0.00M |
|
$-949.00 |
|
$-949.00 |
|
| Balance Sheet Financials | |
$557.54M |
|
$1.96M |
|
$134.76M |
|
$692.29M |
|
$46.41M |
|
-- |
|
$9.98M |
|
$56.39M |
|
$-356.46M |
|
$635.91M |
|
$635.91M |
|
0.02M |
|
| Cash Flow Statement Financials | |
$-120.21M |
|
$-492.60M |
|
$598.66M |
|
$175.18M |
|
$161.03M |
|
$-14.15M |
|
$10.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-122.30M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
41.79% |
|
-23.42% |
|
-21.52% |
|
-23.42% |
|
$0.03M |
|
-- |
|
-- |
|